✓ Last verified: February 20, 2026 — Edited & verified by Angelica Bottaro for HealingMaps Editorial Staff
Known For: The only private Spravato therapy provider in southern Maine, with a dual focus on mental health and addiction recovery led by a Tufts-affiliated psychiatrist with over 20 years of experience.
| Review Scores | Contact clinic for reviews |
| Location | South Portland, ME |
| Address | 10 Atlantic Pl, South Portland, ME 04106 |
| Phone | (207) 482-0276 |
| Website | co-recover.com |
| Treatments | Spravato (Esketamine Nasal Spray), Psychiatric Medication Management, Addiction Counseling, Mental Health Counseling |
| Conditions Treated | Treatment-Resistant Depression, Substance Use Disorders, Co-Occurring Disorders, Depression, Anxiety |
| Cost | Contact clinic for pricing |
| Insurance | Contact clinic; Spravato often covered by insurance |
| Clinical Lead | Edward J. Bilotti, MD — Board-Certified Psychiatrist, Addiction Medicine Specialist, Clinical Assistant Professor at Tufts |
HealingMaps Take: CoRecover occupies a unique niche in Maine’s ketamine landscape: it is the only private Spravato (esketamine) provider in southern Maine, and it serves a population that most ketamine clinics do not prioritize — patients with co-occurring mental health and substance use disorders. Led by Dr. Edward J. Bilotti, a board-certified psychiatrist and addiction medicine specialist with over 20 years of clinical experience, CoRecover brings academic-caliber expertise to the South Portland community. Dr. Bilotti is a Clinical Assistant Professor at Tufts University School of Medicine, a Fellow of the American Psychiatric Association, and previously served as Medical Director of multiple programs at Maine Medical Center. His background in both psychiatry and addiction medicine makes CoRecover the right fit for patients whose depression intersects with substance use — a combination that many standalone infusion clinics are not equipped to manage. The Spravato model also means patients are more likely to have insurance coverage than with IV ketamine.
Market Position: CoRecover is a Spravato-certified clinic in the Portland metro. Spravato (esketamine) is the FDA-approved ketamine treatment that most commercial insurance plans cover after prior authorization — unlike cash-pay IV ketamine.
Industry pricing reference. CoRecover has not published specific per-session pricing — contact the clinic directly for a quote. The calculator above shows typical metro-level cost estimates across protocols, not this clinic’s specific prices.
| Protocol | Typical Industry Cost | Offered Here |
|---|---|---|
| IV Ketamine | $350–$650/session | — |
| Spravato (esketamine) | $0–$250 copay (insured) | ✓ Yes |
| IM Ketamine | $250–$400/injection | — |
| KAP (with therapist) | $400–$1,200/session | — |
| At-home troches | $150–$300/month | — |
Sources: CDC PLACES 2023 (Cumberland County, ME, crude prevalence) · U.S. Census ACS 5 Year · HealingMaps proprietary patient inquiry data.
Behind this data: HealingMaps has analyzed 23,496 patient inquiries (Oct 2022 – Mar 2026), mapped 1,473 verified clinics across 3,142 counties, scraped 132 clinic pricing pages, and collected 658 practitioner survey responses. This snapshot reflects our multi-source methodology.
75% of ketamine patients report zero insurance coverage for their treatment — meaning most patients pay cash and should factor the full cost of care into their treatment decision. Source: HealingMaps 2026 Ketamine Clinic Intelligence Report — drawn from 23,496 patient inquiries and 132 clinic website analyses.
This 3-question summary is matched to the protocols and conditions CoRecover treats. Editorial responses are HealingMaps-authored, grounded in our 2026 Ketamine Clinic Intelligence Report.
Yes — CoRecover offers Spravato, which means they’re FDA REMS-certified and maintain the required two-hour in-office monitoring window after each dose. Spravato is the primary insurance-covered ketamine option for treatment-resistant depression. Worth confirming the prior-authorization timeline before booking your first session.
CoRecover treats depression via Spravato (FDA-approved for TRD). The Spravato pathway is the most likely to obtain commercial insurance coverage. TRD is typically defined as two or more prior antidepressant trials without sufficient response — patients meeting that bar are best candidates here.
Yes — CoRecover treats anxiety, including generalized anxiety, social anxiety, and panic disorder. The evidence base for ketamine in anxiety is less robust than for depression, but it can be a meaningful option for patients who haven’t responded to SSRIs or benzodiazepines. Worth asking which of their protocols they typically recommend for anxiety-primary patients.
View all REMS-certified Spravato clinics in Maine and across the United States.
Leave a Reply